Search

everythinglearnresearchcommunity

for

Search:↓

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

TNF-alpha inhibitors can cause various immune-related skin issues.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Certain bacteria can enhance skin regeneration.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Exosomes could be key in treating skin conditions and healing wounds.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Apremilast shows promise for several skin conditions but needs more research.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.